TY - JOUR
T1 - Management of frailty
T2 - opportunities, challenges, and future directions
AU - Dent, Elsa
AU - Martin, Finbarr C.
AU - Bergman, Howard
AU - Woo, Jean
AU - Romero-Ortuno, Roman
AU - Walston, Jeremy D.
PY - 2019/10/12
Y1 - 2019/10/12
N2 - Frailty is a complex age-related clinical condition characterised by a decline in physiological capacity across several organ systems, with a resultant increased susceptibility to stressors. Because of the heterogeneity of frailty in clinical presentation, it is important to have effective strategies for the delivery of care that range across the continuum of frailty severity. In clinical practice, we should do what works, starting with frailty screening, case identification, and management of frailty. This process is unarguably difficult given the absence of an adequate evidence base for individual and health-system interventions to manage frailty. We advocate change towards individually tailored interventions that preserve an individual's independence, physical function, and cognition. This change can be addressed by promoting the recognition of frailty, furthering advancements in evidence-based treatment options, and identifying cost-effective care delivery strategies.
AB - Frailty is a complex age-related clinical condition characterised by a decline in physiological capacity across several organ systems, with a resultant increased susceptibility to stressors. Because of the heterogeneity of frailty in clinical presentation, it is important to have effective strategies for the delivery of care that range across the continuum of frailty severity. In clinical practice, we should do what works, starting with frailty screening, case identification, and management of frailty. This process is unarguably difficult given the absence of an adequate evidence base for individual and health-system interventions to manage frailty. We advocate change towards individually tailored interventions that preserve an individual's independence, physical function, and cognition. This change can be addressed by promoting the recognition of frailty, furthering advancements in evidence-based treatment options, and identifying cost-effective care delivery strategies.
UR - http://www.scopus.com/inward/record.url?scp=85072917235&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(19)31785-4
DO - 10.1016/S0140-6736(19)31785-4
M3 - Review article
C2 - 31609229
AN - SCOPUS:85072917235
SN - 0140-6736
VL - 394
SP - 1376
EP - 1386
JO - The Lancet
JF - The Lancet
IS - 10206
ER -